First-In-Human Data About The Treatment Of Muscle-Invasive Bladder Cancer With Pentixapharm’S Lu177-Pentixather To Be Presented At ASCO-GU 2025
Berlin, Germany, February 13, 2025 – Data from the first-in-human radioligand-therapy for muscle invasive bladder cancer (MIBC) using Pentixapharm's Lu177-PentixaTher compound will be shown at the ...
The Local10h
MAP: Which parts of France are most popular with British second-home buyers?
Having a second home in France is a dream for many British people - but there is a clear trend in the areas most popular with ...
PharmiWeb13h
First-In-Human Data about the Treatment of Muscle-…
ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...